153 related articles for article (PubMed ID: 30765682)
21. Successful treatment of advanced gastric cancer by surgical resection following combination chemotherapy with oral S-1 and biweekly paclitaxel.
Nakajo A; Natsugoe S; Hokita S; Ishigami S; Takatori H; Arigami T; Uenosono Y; Aridome K; Aikou T
Gastric Cancer; 2007; 10(1):58-62. PubMed ID: 17334720
[TBL] [Abstract][Full Text] [Related]
22. A patient with gastric cancer with peritoneal carcinomatosis treated with intraperitoneal chemotherapy who survived more than 5 years receiving repeated laparoscopic examinations: a case report.
Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Nishikawa T; Tanaka J; Tanaka T; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Ishihara S; Sunami E; Watanabe T
J Med Case Rep; 2016 Jan; 10():14. PubMed ID: 26786355
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
J Surg Oncol; 2012 Jan; 105(1):38-42. PubMed ID: 21882194
[TBL] [Abstract][Full Text] [Related]
24. [Advanced Gastric Cancer with Peritoneal Dissemination Treated with Conversion Surgery after S-1 and CDDP Chemotherapy - A Case Report].
Matsuda Y; Nakamura T; Ueta K; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Oshikiri T; Matsuda T; Sumi Y; Suzuki S; Kakeji Y
Gan To Kagaku Ryoho; 2018 Mar; 45(3):471-473. PubMed ID: 29650908
[TBL] [Abstract][Full Text] [Related]
25. Intraperitoneal Administration of Paclitaxel Followed by Paclitaxel, Cisplatin, and S-1 Chemotherapy for Cytology-positive Gastric Cancer: A Feasibility Study.
Shinkai M; Imano M; Chiba Y; Hiraki Y; Kato H; Iwama M; Shiraisi O; Yasuda A; Tsubaki M; Nishida S; Kimura Y; Yasuda T
Anticancer Res; 2018 Oct; 38(10):5969-5974. PubMed ID: 30275227
[TBL] [Abstract][Full Text] [Related]
26. [A successfully treated case of type 4 gastric cancer with intraperitoneal free cancer cells undergoing a curative resection followed by neoadjuvant chemotherapy with S-1 plus cisplatin].
Koizumi S; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D; Tateishi Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2464-6. PubMed ID: 21224607
[TBL] [Abstract][Full Text] [Related]
27. [Curative resection for Stage IV advanced gastric cancer that responded to combination chemotherapy with docetaxel, cisplatin, and S-1].
Nishiuchi A; Nishino H; Kato S; Kadokawa Y; Machimoto T; Asao Y; Furuyama H; Yoshimura T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2305-7. PubMed ID: 25731504
[TBL] [Abstract][Full Text] [Related]
28. [A case report of curative resection for gastric cancer with peritoneal dissemination successfully treated by combined chemotherapy of S-1 and paclitaxel].
Yamaki S; Iwata S; Ohtsuka K; Kitaoka A; Masumoto H; Katoh H
Gan To Kagaku Ryoho; 2008 May; 35(5):821-3. PubMed ID: 18487921
[TBL] [Abstract][Full Text] [Related]
29. [A case of advanced gastric cancer responding to neoadjuvant S-1/CDDP therapy].
Matsui K; Nashimoto A; Nakagawa S; Nomura T; Yabusaki H; Takii Y; Tsuchiya Y; Tanaka O; Ohta T
Gan To Kagaku Ryoho; 2008 Mar; 35(3):499-501. PubMed ID: 18347404
[TBL] [Abstract][Full Text] [Related]
30. [A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy].
Ebisui C; Souma I; Hayashi N; Fukuchi N; Izawa H; Yoshida T; Sakita I; Hasuike Y; Fujimoto T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1861-3. PubMed ID: 15553740
[TBL] [Abstract][Full Text] [Related]
31. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy.
Yasufuku I; Nunobe S; Ida S; Kumagai K; Ohashi M; Hiki N; Sano T
Gastric Cancer; 2020 Mar; 23(2):319-327. PubMed ID: 31350702
[TBL] [Abstract][Full Text] [Related]
32. [Curative resection of a case of advanced gastric cancer with peritoneal dissemination responding well to combination chemotherapy of docetaxel,cisplatin and S-1].
Nemoto H; Sato T; Rino Y; Uchiyama M; Atsumi Y; Hasegawa S; Tamagawa H; Oshima T; Yukawa N; Yoshikawa T; Imada T; Masuda M
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1221-4. PubMed ID: 24047784
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer.
Shinkai M; Imano M; Chiba Y; Iwama M; Shiraisi O; Yasuda A; Tsubaki M; Nishida S; Kimura Y; Yasuda T
J Surg Oncol; 2019 Jan; 119(1):56-63. PubMed ID: 30444009
[TBL] [Abstract][Full Text] [Related]
34. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
[TBL] [Abstract][Full Text] [Related]
35. [A case of advanced gastric cancer with peritoneal dissemination responding to S-1/CDDP neoadjuvant chemotherapy].
Mizutani S; Oyama T; Uchikoshi F; Yoshidome K; Tori M; Ueshima S; Hiraoka K; Yamagami Y; Takahashi H; Nakahara M
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1853-6. PubMed ID: 18030023
[TBL] [Abstract][Full Text] [Related]
36. [A Case of Type 4 Gastric Cancer with Peritoneal Dissemination Successfully Treated with Conversion Surgery after Intensive S-1 plus Oxaliplatin Chemotherapy].
Obana A; Usui S; Koyama M; Koide N; Iwasaki K; Matsumura T; Sato Y; Kitamura K; Yoshida R; Nomori H; Suwa T
Gan To Kagaku Ryoho; 2021 Jan; 48(1):95-97. PubMed ID: 33468732
[TBL] [Abstract][Full Text] [Related]
37. [A Case of Peritoneal Dissemination of Metastatic Gastric Cancer with Successful Docetaxel and S-1 Combination Therapy].
Kato S; Nishikawa K; Hirao M; Hamakawa T; Fujiwara A; Maeda S; Uemura M; Miyake M; Hama N; Miyamoto A; Miyazaki M; Kato T; Takami K; Nakamori S; Sekimoto M
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2375-2377. PubMed ID: 30692469
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial.
Kodera Y; Takahashi N; Yoshikawa T; Takiguchi N; Fujitani K; Ito Y; Miyamoto K; Takayama O; Imano M; Kobayashi D; Miyashita Y; Morita S; Sakamoto J
Gastric Cancer; 2017 Jan; 20(1):190-199. PubMed ID: 26879545
[TBL] [Abstract][Full Text] [Related]
39. [A Case of Remnant Gastric Cancer That Completely Responded to Neoadjuvant S-1 and Cisplatin Therapy].
Shimaoka H; Shibata R; Hosoda Y; Hirano Y; Munechika T; Yonemitsu K; Ishii Y; Okamoto T; Maeno H; Noritomi T; Yoshida T; Sueishi K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1220-1222. PubMed ID: 29394587
[TBL] [Abstract][Full Text] [Related]
40. The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
Sasaki K; Natsugoe S; Aridome K; Ishigami S; Hokita S; Aikou T
Hepatogastroenterology; 2007 Dec; 54(80):2421-4. PubMed ID: 18265679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
